Drugs / Fluzone High-Dose Quadrivalent
Fluzone High-Dose Quadrivalent
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03698279 | Oct 2018 → Oct 2019 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05050318 | Sep → Nov 2021 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT06361875 Comparator | Apr 2024 → Jun 2025 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 1/2 | NCT05650554 Comparator | Dec 2022 → Apr 2024 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 1/2 | NCT05553301 Comparator | Oct 2022 → Jan 2024 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05007041 Comparator | Sep 2021 → Mar 2023 | — | Duke University | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2022-06-22 | Sanofi | Media Update: Survey: Physicians and pharmacists would tell CDC to recommend vaccine like Fluzone High-Dose Quadrivalent (Influenza Vaccine) for people 65 years and older sanofi.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone High-Dose Quadrivalent | “Quadrivalent high-dose inactivated influenza vaccine (Fluzone® High-Dose Quadrivalent, IIV4-HD) was licensed in the USA in 2019 for adults ≥ 65 years of age.” PMID 33610374 ↗ Feb 2021 |
| Known as | IIV4-HD | “Quadrivalent high-dose inactivated influenza vaccine (Fluzone® High-Dose Quadrivalent, IIV4-HD) was licensed in the USA in 2019 for adults ≥ 65 years of age.” PMID 33610374 ↗ Feb 2021 |
| Known as | Quadrivalent Influenza High-Dose Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05650554 ↗ |
| Modality | Vaccine | “Quadrivalent high-dose inactivated influenza vaccine” PMID 33610374 ↗ Feb 2021 |
| Route | Intramuscular | “received 1 or 2 doses intramuscularly” PMID 33610374 ↗ Feb 2021 |